James N. Topper, Director at Phathom Pharmaceuticals, Inc. (PHAT), bought 81,579 shares at $3.19 ($259K) on 2025-05-09, disclosed to the SEC on 2025-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.19 | 33,376 | $106K | 41.1% |
| 2 | $3.19 | 33,376 | $106K | 41.1% |
| 3 | $3.62 | 2,226 | $8K | 3.1% |
| 4 | $3.04 | 12,601 | $38K | 14.8% |
| Total | $3.18 avg | 81,579 | $259K | 100% |
| Filing → |
| NAMS | BUY | 2025-08-13 | $11K | — | Filing → |
| NAMS | BUY | 2025-06-26 | $69K | — | Filing → |
| NAMS | BUY | 2025-06-18 | $167K | — | Filing → |